Loading…

Loading grant details…

Active HORIZON European Commission

Platform Optimisation To Enable NanomaTerIAL safety assessment for rapid commercialisation

€3M EUR

Funder European Commission
Recipient Organization Istituto Di Ricerche Farmacologiche Mario Negri
Country Italy
Start Date Jan 01, 2023
End Date Dec 31, 2026
Duration 1,460 days
Number of Grantees 12
Roles Participant; Coordinator; Associated Partner
Data Source European Commission
Grant ID 101092901
Grant Description

Advanced Nanomaterials (Ad-NMs) will lead a new industrial revolution and accelerate the transition to greener technologies and better health care.

However, lack of practical and reliable protocols to evaluate Ad-NMs' potential hazards and risks has hindered innovation so far.

POTENTIAL will generate a methodological framework comprising a set of harmonised protocols for characterisation, testing, grouping and read-across of Ad-NMs, that meet regulatory requirements for risk assessment, by improving:a) Advanced imaging protocols to quantify and characterize the intrinsic and extrinsic properties of Ad-NMs in complex matrices, using conventional analytical methods. b) Protocols to trace the evolution of Ad-NMs properties throughout their lifecycle, and methodologies for accelerated testing. c) in vitro multi-cellular models, in vivo (invertebrate) models, and ecotoxicological models for assessing the environmental and health hazard of Ad-NMs.Grouping and read-across approaches will build up on results from existing Horizon initiatives (GRACIOUS, SUNSHINE and HARMLESS), and will generate novel algorithms for similarity assessment, grouping hypotheses and Integrated Approaches to Testing and Assessments (IATAs).The protocols generated in the project will be validated through peer-reviewed publications and disseminated in Open Access.

Furthermore, we will engage with the relevant standardisation bodies and organisations (OECD, ISO, CEN) to ensure that our approach can be translated into industry standards.The consortium comprises 11 European partners and 1 international partner (China), among which 4 high-tech SMEs specialised in Ad-NMs, and a high-tech incubator / accelerator.

POTENTIAL contributes to the Horizon Europe workprogram by helping establish appropriate methods for cost-efficient assessment and prediction of the health and environmental effects of Ad-NMs, as well as supporting the inclusion of new methods to support safe-and-sustainable-by-design.

All Grantees

Asociacion Centro de Investigacion Cooperativa En Biomateriales- Cic Biomagune; Mybiotech Gmbh; Universite Paris 13; Innova Srl; Istituto Di Ricerche Farmacologiche Mario Negri; Graphenea Sa; Zhejiang University; Luxembourg Institute of Science and Technology; Universitaet Leipzig; Greendecision Srl; East European Research and Innovation Enterprise Ltd; Royal College of Surgeons in Ireland

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant